NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 7.64% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 7.49% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.09% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 7.03% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 6.74% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.95% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.54% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 3.36% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.35% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.27% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 3.02% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.98% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.95% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.66% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.57% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.56% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.11% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.95% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.92% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.74% |